|
| 35904816 | FACT subunit SUPT16H associates with BRD4 and contributes to silencing of interferon signaling. | Nucleic Acids Res | 2022 |
| 36177032 | SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling. | Front Immunol | 2022 |
| 35904816 | FACT subunit SUPT16H associates with BRD4 and contributes to silencing of interferon signaling. | Nucleic Acids Res | 2022 |
| 36177032 | SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling. | Front Immunol | 2022 |
| 34297745 | Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination. | PLoS Pathog | 2021 |
| 34297745 | Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination. | PLoS Pathog | 2021 |
| 34075374 | SARS-CoV-2 Nsp14 activates NF-κB signaling and induces IL-8 upregulation. | bioRxiv | 2021 |
| 33907746 | FACT subunit SUPT16H associates with BRD4 and contributes to silencing of antiviral interferon signaling. | bioRxiv | 2021 |
| 33907746 | FACT subunit SUPT16H associates with BRD4 and contributes to silencing of antiviral interferon signaling. | bioRxiv | 2021 |
| 34075374 | SARS-CoV-2 Nsp14 activates NF-κB signaling and induces IL-8 upregulation. | bioRxiv | 2021 |
| 32176734 | Nucleolar protein NOP2/NSUN1 suppresses HIV-1 transcription and promotes viral latency by competing with Tat for TAR binding and methylation. | PLoS Pathog | 2020 |
| 32176734 | Nucleolar protein NOP2/NSUN1 suppresses HIV-1 transcription and promotes viral latency by competing with Tat for TAR binding and methylation. | PLoS Pathog | 2020 |
| 32841292 | Profiling of immune related genes silenced in EBV-positive gastric carcinoma identified novel restriction factors of human gammaherpesviruses. | PLoS Pathog | 2020 |
| 32832623 | Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4<sup>+</sup> T cells ex vivo. | Sci Adv | 2020 |
| 32832623 | Inhibition of Polo-like kinase 1 (PLK1) facilitates the elimination of HIV-1 viral reservoirs in CD4<sup>+</sup> T cells ex vivo. | Sci Adv | 2020 |
| 32841292 | Profiling of immune related genes silenced in EBV-positive gastric carcinoma identified novel restriction factors of human gammaherpesviruses. | PLoS Pathog | 2020 |
| 31165872 | A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG). | Nucleic Acids Res | 2019 |
| 31494268 | Diversified Application of Barcoded PLATO (PLATO-BC) Platform for Identification of Protein Interactions. | Genomics Proteomics Bioinformatics | 2019 |
| 31165872 | A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG). | Nucleic Acids Res | 2019 |
| 31101492 | Enhancing the ligand efficiency of anti-HIV compounds targeting frameshift-stimulating RNA. | Bioorg Med Chem | 2019 |
| 30989696 | Curaxin CBL0137 has the potential to reverse HIV-1 latency. | J Med Virol | 2019 |
| 31494268 | Diversified Application of Barcoded PLATO (PLATO-BC) Platform for Identification of Protein Interactions. | Genomics Proteomics Bioinformatics | 2019 |
| 31101492 | Enhancing the ligand efficiency of anti-HIV compounds targeting frameshift-stimulating RNA. | Bioorg Med Chem | 2019 |
| 30989696 | Curaxin CBL0137 has the potential to reverse HIV-1 latency. | J Med Virol | 2019 |
| 29740418 | Inhibition of Tip60 Reduces Lytic and Latent Gene Expression of Kaposi's Sarcoma-Associated Herpes Virus (KSHV) and Proliferation of KSHV-Infected Tumor Cells. | Front Microbiol | 2018 |
| 30496325 | Specificity and functional interplay between influenza virus PA-X and NS1 shutoff activity. | PLoS Pathog | 2018 |
| 29740418 | Inhibition of Tip60 Reduces Lytic and Latent Gene Expression of Kaposi's Sarcoma-Associated Herpes Virus (KSHV) and Proliferation of KSHV-Infected Tumor Cells. | Front Microbiol | 2018 |
| 30496325 | Specificity and functional interplay between influenza virus PA-X and NS1 shutoff activity. | PLoS Pathog | 2018 |
| 28842263 | Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription. | Antiviral Res | 2017 |
| 28638377 | A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association. | Front Microbiol | 2017 |
| 28842263 | Screening of an FDA-approved compound library identifies levosimendan as a novel anti-HIV-1 agent that inhibits viral transcription. | Antiviral Res | 2017 |
| 28368303 | Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency. | Viruses | 2017 |
| 29089933 | Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation. | Front Microbiol | 2017 |
| 28368303 | Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency. | Viruses | 2017 |
| 29089933 | Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation. | Front Microbiol | 2017 |
| 28638377 | A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association. | Front Microbiol | 2017 |
| 25776761 | IFI44 suppresses HIV-1 LTR promoter activity and facilitates its latency. | Virology | 2015 |
| 25776761 | IFI44 suppresses HIV-1 LTR promoter activity and facilitates its latency. | Virology | 2015 |
| 26378236 | FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency. | J Biol Chem | 2015 |
| 26378236 | FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency. | J Biol Chem | 2015 |
| 25313082 | Characterization of HPV and host genome interactions in primary head and neck cancers. | Proc Natl Acad Sci U S A | 2014 |
| 25313082 | Characterization of HPV and host genome interactions in primary head and neck cancers. | Proc Natl Acad Sci U S A | 2014 |
| 21691089 | Polycystin-1, 2, and STIM1 interact with IP(3)R to modulate ER Ca release through the PI3K/Akt pathway. | Cell Physiol Biochem | 2011 |
| 21691089 | Polycystin-1, 2, and STIM1 interact with IP(3)R to modulate ER Ca release through the PI3K/Akt pathway. | Cell Physiol Biochem | 2011 |
| 19854836 | Polycystin-1 interacts with inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling with implications for polycystic kidney disease. | J Biol Chem | 2009 |
| 19854836 | Polycystin-1 interacts with inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling with implications for polycystic kidney disease. | J Biol Chem | 2009 |